TrialLeukemia2026

Treatment-free remission after two nilotinib consolidation durations in chronic myeloid leukemia treated with imatinib: Phase 3 ENESTPath results.

Delphine Rea et al.PubMed ↗Publisher ↗

No numbers read from the abstract.